279 related articles for article (PubMed ID: 9664234)
41. Response of growing swine to dietary exposure to pure fumonisin B1 during an eight-week period: growth and clinical parameters.
Rotter BA; Thompson BK; Prelusky DB; Trenholm HL; Stewart B; Miller JD; Savard ME
Nat Toxins; 1996; 4(1):42-50. PubMed ID: 8680753
[TBL] [Abstract][Full Text] [Related]
42. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
[TBL] [Abstract][Full Text] [Related]
43. Effects of intravenous fumonisin B1 in rabbits: nephrotoxicity and sphingolipid alterations.
Gumprecht LA; Marcucci A; Weigel RM; Vesonder RF; Riley RT; Showker JL; Beasley VR; Haschek WM
Nat Toxins; 1995; 3(5):395-403. PubMed ID: 8581326
[TBL] [Abstract][Full Text] [Related]
44. The effect of fumonisin B1 on developing chick embryos: correlation between de novo sphingolipid biosynthesis and gross morphological changes.
Zacharias C; van Echten-Deckert G; Wang E; Merrill AH; Sandhoff K
Glycoconj J; 1996 Apr; 13(2):167-75. PubMed ID: 8737241
[TBL] [Abstract][Full Text] [Related]
45. Mechanism of the mitogenic and carcinogenic action of fumonisin B1, a mycotoxin.
Wolf G
Nutr Rev; 1994 Jul; 52(7):246-7. PubMed ID: 8090377
[TBL] [Abstract][Full Text] [Related]
46. DNA damage in astrocytes exposed to fumonisin B1.
Galvano F; Campisi A; Russo A; Galvano G; Palumbo M; Renis M; Barcellona ML; Perez-Polo JR; Vanella A
Neurochem Res; 2002 Apr; 27(4):345-51. PubMed ID: 11958538
[TBL] [Abstract][Full Text] [Related]
47. Effects of fumonisin B1-contaminated feeds on weanling angora goats.
Gurung NK; Rankins DL; Shelby RA; Goel S
J Anim Sci; 1998 Nov; 76(11):2863-70. PubMed ID: 9856397
[TBL] [Abstract][Full Text] [Related]
48. Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B(1) as an example.
Dragan YP; Bidlack WR; Cohen SM; Goldsworthy TL; Hard GC; Howard PC; Riley RT; Voss KA
Toxicol Sci; 2001 May; 61(1):6-17. PubMed ID: 11294969
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.
Wang E; Norred WP; Bacon CW; Riley RT; Merrill AH
J Biol Chem; 1991 Aug; 266(22):14486-90. PubMed ID: 1860857
[TBL] [Abstract][Full Text] [Related]
50. Toxicity of culture material of Fusarium verticillioides strain MRC 826 to nonhuman primates.
Gelderblom WC; Seier JV; Snijman PW; Van Schalkwyk DJ; Shephard GS; Marasas WF
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):267-76. PubMed ID: 11359695
[TBL] [Abstract][Full Text] [Related]
51. Effects of fumonisin B1 in pregnant rats. Part 2.
Collins TF; Sprando RL; Black TN; Shackelford ME; Laborde JB; Hansen DK; Eppley RM; Trucksess MW; Howard PC; Bryant MA; Ruggles DI; Olejnik N; Rorie JI
Food Chem Toxicol; 1998 Aug; 36(8):673-85. PubMed ID: 9734718
[TBL] [Abstract][Full Text] [Related]
52. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
[TBL] [Abstract][Full Text] [Related]
53. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
54. A mechanistic approach to modelling the risk of liver tumours in mice exposed to fumonisin B1 in the diet.
Kodell RL; Young JF; Delongchamp RR; Turturro A; Chen JJ; Gaylor DW; Howard PC; Zheng Q
Food Addit Contam; 2001 Mar; 18(3):237-53. PubMed ID: 11304033
[TBL] [Abstract][Full Text] [Related]
55. Intravenous fumonisin B1 induces cell proliferation and apoptosis in the rat.
Lim CW; Parker HM; Vesonder RF; Haschek WM
Nat Toxins; 1996; 4(1):34-41. PubMed ID: 8680752
[TBL] [Abstract][Full Text] [Related]
56. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
[TBL] [Abstract][Full Text] [Related]
57. Fumonisin B(1) is hepatotoxic and nephrotoxic in milk-fed calves.
Mathur S; Constable PD; Eppley RM; Waggoner AL; Tumbleson ME; Haschek WM
Toxicol Sci; 2001 Apr; 60(2):385-96. PubMed ID: 11248152
[TBL] [Abstract][Full Text] [Related]
58. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
Merrill AH; Sullards MC; Wang E; Voss KA; Riley RT
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):283-9. PubMed ID: 11359697
[TBL] [Abstract][Full Text] [Related]
59. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks.
Tardieu D; Tran ST; Auvergne A; Babilé R; Benard G; Bailly JD; Guerre P
Chem Biol Interact; 2006 Mar; 160(1):51-60. PubMed ID: 16412405
[TBL] [Abstract][Full Text] [Related]
60. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1.
Sharma RP; Bhandari N; He Q; Riley RT; Voss KA
Toxicology; 2001 Feb; 159(1-2):69-79. PubMed ID: 11250056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
